Novartis Patent in India — research background
This directory groups existing GIPResearch.com articles associated with Novartis Patent in India. Entries represent previously published material, not a current patent-register or regulatory determination.
Novartis AG Receives Patent in India for Glycoside Derivatives to Treat Diabetes
NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.
NOVARTIS AG Received a Patent for Purification Method
NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.
NOVARTIS AG Received a Patent for Various Inhibitors
NOVARTIS AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The disease focus areas of Novartis.
Novartis AG Received a Patent for MANUFACTURING 5-(2,6-DI-4-MORPHOLINYL-4-PYRIMIDINYL)-4-TRIFLUORO-METHYLPYRIDIN-2-AMINE
Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital.
Discuss a research question related to Novartis Patent in India
Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.
Discuss a research questionDiscuss a research question related to Novartis Patent in India
Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.
Discuss a research questionSource and context: Original GIPResearch.com publication. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

How to patent fintech inventions
Gen AI Innovations
What is Extended Reality
How to patent artificial intelligence based innovations
Patent claim drafting